共 50 条
- [41] Deconstructing protein and gene expression pathways to define the anticancer effects of XPO1 inhibition in ovarian cancerCANCER RESEARCH, 2015, 75Evans, Brad R.Silvers, Thomas R.Chen, Ying A.Garcia, JasonCamacho, CatalinaSharp, Andrew J.Garag, ParasKoduru, Srinivas V.Billaud, Jean-NoelHalpert, Richard L.Dottino, Peter R.Landesman, YosefShacham, SharonMartignetti, John A.
- [42] Inhibition of XPO1 impairs cholangiocarcinoma cell proliferation by triggering p53 intranuclear accumulationCANCER MEDICINE, 2023, 12 (05): : 5751 - 5763Zhao, ChengMa, BenYang, Zi-yiLi, OuLiu, Shi-leiPan, Li-jiaGong, WeiDong, PingShu, Yi-jun
- [43] XPO1 Inhibition Disrupts Ribosomal Subunits Assembly and Induces Multiple Myeloma (MM) Cell DeathBLOOD, 2013, 122 (21)Tagoug, InesNeri, PaolaSlaby, JiriBabich, JacquelynSimms, JustinGratton, KathyRen, LiBahlis, Nizar J.
- [44] Inhibition of exportin 1 (XPO1) by selinexor (KPT-330) synergistically suppresses growth of neuroblastoma in combination with doxorubicin or bromodomain inhibitionCANCER RESEARCH, 2015, 75Ranieri, Pietro J.Trillo, RebeccaLandesman, YosefSenapedis, WilliamMcCauley, DilaraShacham, SharonKauffman, MichaelMaris, John M.Attiyeh, Edward F.
- [45] XPO1 Inhibition Preferentially Disrupts the 3D Nuclear Organization of Telomeres in Tumor CellsJOURNAL OF CELLULAR PHYSIOLOGY, 2016, 231 (12) : 2711 - 2719Taylor-Kashton, CherylLichtensztejn, DanielBaloglu, ErkanSenapedis, WilliamShacham, SharonKauffman, Michael G.Kotb, RamiMai, Sabine
- [46] Discovery, Validation and Mechanistic Study of XPO1 Inhibition in the Treatment of Triple-Negative Breast CancerCANCERS, 2024, 16 (23)Paulson, Amy L.Gruener, Robert F.Lee, Adam M.Huang, R. Stephanie
- [47] Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian CancerCLINICAL CANCER RESEARCH, 2017, 23 (06) : 1552 - 1563Chen, YingCamacho, Sandra CatalinaSilvers, Thomas R.Razak, Albiruni R. A.Gabrail, Nashat Y.Gerecitano, John F.Kalir, EvaPereira, ElenaEvans, Brad R.Ramus, Susan J.Huang, FeiPriedigkeit, NolanRodriguez, EstefaniaDonovan, MichaelKhan, FaisalKalir, TamaraSebra, RobertUzilov, AndrewChen, RongSinha, RileenHalpert, RichardBillaud, Jean-NoelShacham, SharonMcCauley, DilaraLandesman, YosefRashal, TamiKauffman, MichaelMirza, Mansoor R.Mau-Sorensen, MortenDottino, PeterMartignetti, John A.
- [48] Use of selective inhibition of nuclear export (SINE) using a CRM1/XPO1 antagonist to overcome resistance to CPT-11 in colon cancer in preclinical modelsJOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)Chung, Hye WonFragomeni, Roberto A. SalasShacham, SharonKauffman, MichaelCusack, James C.
- [49] Hitting a moving target: inhibition of the nuclear export receptor XPO1/CRM1 as a therapeutic approach in cancerCANCER DRUG RESISTANCE, 2018, 1 (03) : 139 - 163Sendino, MariaJosu Omaetxebarria, MirenAntonio Rodriguez, Jose
- [50] XPO1 is selinexor prime target: validation by mutating cysteine 528 on both XPO1 alleles using CRISPR/Cas9 genome editingCANCER RESEARCH, 2015, 75Neggers, Jasper E.Vercruysse, ThomasJacquemyn, MaartenVanstreels, ElsBaloglu, ErkanShacham, SharonCrochiere, MarshaSenapedis, WilliamLandesman, YosefDaelemans, Dirk